Boundless Bio Statistics Share Statistics Boundless Bio has 22.39M
shares outstanding. The number of shares has increased by 0.59%
in one year.
Shares Outstanding 22.39M Shares Change (YoY) 0.59% Shares Change (QoQ) 0.38% Owned by Institutions (%) 76.1% Shares Floating 14.94M Failed to Deliver (FTD) Shares 231 FTD / Avg. Volume 0.13%
Short Selling Information The latest short interest is 75.42K, so 0.34% of the outstanding
shares have been sold short.
Short Interest 75.42K Short % of Shares Out 0.34% Short % of Float 0.59% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.75 and the forward
PE ratio is -0.45.
Boundless Bio's PEG ratio is
-0.01.
PE Ratio -0.75 Forward PE -0.45 PS Ratio 0 Forward PS n/a PB Ratio 0.33 P/FCF Ratio -0.78 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Boundless Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 18.98,
with a Debt / Equity ratio of 0.32.
Current Ratio 18.98 Quick Ratio 18.98 Debt / Equity 0.32 Debt / EBITDA -0.74 Debt / FCF -0.75 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.02M Employee Count 64 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -61.81% in the
last 52 weeks. The beta is -0.46, so Boundless Bio's
price volatility has been lower than the market average.
Beta -0.46 52-Week Price Change -61.81% 50-Day Moving Average 1.13 200-Day Moving Average 1.91 Relative Strength Index (RSI) 38.18 Average Volume (20 Days) 180,170
Income Statement
Revenue n/a Gross Profit -1.09M Operating Income -73.27M Net Income -65.36M EBITDA -64.28M EBIT -65.36M Earnings Per Share (EPS) -3.85
Full Income Statement Balance Sheet The company has 26.59M in cash and 47.63M in
debt, giving a net cash position of -21.05M.
Cash & Cash Equivalents 26.59M Total Debt 47.63M Net Cash -21.05M Retained Earnings -201.47M Total Assets 179.45M Working Capital 120.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -60.84M
and capital expenditures -2.54M, giving a free cash flow of -63.38M.
Operating Cash Flow -60.84M Capital Expenditures -2.54M Free Cash Flow -63.38M FCF Per Share -3.73
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
